# Intra-articular Injections for Knee Osteoarthritis: A Single Blinded Prospective Randomized Trial

> **NCT02995083** · EARLY_PHASE1 · WITHDRAWN · sponsor: **Rush University Medical Center**

## Conditions studied

- Symptomatic Osteoarthritis of the Knee

## Interventions

- **DRUG:** 40 mg Depo-Medrol in 1 ml, 9 ml of 1% lidocaine
- **DRUG:** Normal Saline 10 ml
- **DRUG:** Air 10 ml

## Key facts

- **NCT ID:** NCT02995083
- **Lead sponsor:** Rush University Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-06
- **Primary completion:** 2018-01
- **Final completion:** 2018-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study deemed not feasible
- **Last updated:** 2017-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02995083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02995083, "Intra-articular Injections for Knee Osteoarthritis: A Single Blinded Prospective Randomized Trial". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02995083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*